Great Basin Scientific (GBSN) Reports Q2 Loss of $4.10/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P, Nasdaq futures slip as markets await Iran sanctions, Nvidia results
- Oil falls ahead of US announcement of new sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Great Basin Reports Second Quarter 2016 Results
August 11, 2016 4:02 PM EDTCompany sees 38.7% year-over-year revenue growth; continues strong progress toward customer acquisition, assay placement and product development targets
SALT LAKE CITY--(BUSINESS WIRE)-- Great Basin Scientific, Inc. (NASDAQ: GBSN), a molecular diagnostic testing company, today reported financial results for the second quarter ended June 30, 2016.
Second Quarter 2016 Financial Results and Business Highlights
Revenue increased 38.7% to $728,957 compared with a year ago Total installed customer base up 126.1% over last year to 260 Assay adoption rate (assays placed) up 18.2% over last year... More